Actualités/Reuters/EMA committee recommends approval for injectable version of Merck's KeytrudaEMA committee recommends approval for injectable version of Merck's KeytrudaRefinitivMoins d'1 minute de lectureMRKMerck MRK said on Friday the European Medicines Agency's committee has recommended the approval for a new formulation of its MRK blockbuster cancer therapy Keytruda that can be administered under the skin.Actions américainesReuters© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.htmlMontrer plusConnectez-vous ou créez un compte gratuit à vie pour lire ces nouvellesC'est parti
